Found: 147
Select item for more details and to access through your institution.
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
- Published in:
- European Heart Journal, 2024, v. 45, n. 27, p. 2360, doi. 10.1093/eurheartj/ehae304
- By:
- Publication type:
- Article
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease.
- Published in:
- European Heart Journal, 2024, v. 45, n. 27, p. 2362, doi. 10.1093/eurheartj/ehae324
- By:
- Publication type:
- Article
Discontinuation of renin–angiotensin system inhibitors brings no benefits in severe chronic kidney disease.
- Published in:
- European Heart Journal, 2024, v. 45, n. 26, p. 2279, doi. 10.1093/eurheartj/ehae248
- By:
- Publication type:
- Article
Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention—ready for prime time?
- Published in:
- European Heart Journal, 2024, v. 45, n. 25, p. 2183, doi. 10.1093/eurheartj/ehae242
- By:
- Publication type:
- Article
Weekly journal scan: it takes two for acute stroke.
- Published in:
- European Heart Journal, 2024, v. 45, n. 20, p. 1781, doi. 10.1093/eurheartj/ehae166
- By:
- Publication type:
- Article
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle intervention.
- Published in:
- European Heart Journal, 2024, v. 45, n. 16, p. 1392, doi. 10.1093/eurheartj/ehae076
- By:
- Publication type:
- Article
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial.
- Published in:
- European Heart Journal, 2024, v. 45, n. 15, p. 1355, doi. 10.1093/eurheartj/ehad868
- By:
- Publication type:
- Article
Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
- Published in:
- European Heart Journal, 2024, v. 45, n. 10, p. 754, doi. 10.1093/eurheartj/ehad859
- By:
- Publication type:
- Article
Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few.
- Published in:
- European Heart Journal, 2024, v. 45, n. 8, p. 570, doi. 10.1093/eurheartj/ehad823
- By:
- Publication type:
- Article
Edoxaban for atrial high-rate episodes: more harm than good?
- Published in:
- European Heart Journal, 2024, v. 45, n. 5, p. 330, doi. 10.1093/eurheartj/ehad791
- By:
- Publication type:
- Article
Five easy pieces only account for a fraction of incident cardiovascular disease and all-cause deaths.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5024, doi. 10.1093/eurheartj/ehad731
- By:
- Publication type:
- Article
Moving a STEP forward in the treatment of patients with obesity and heart failure with preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 46, p. 4829, doi. 10.1093/eurheartj/ehad674
- By:
- Publication type:
- Article
Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?
- Published in:
- European Heart Journal, 2023, v. 44, n. 43, p. 4506, doi. 10.1093/eurheartj/ehad611
- By:
- Publication type:
- Article
Cardiovascular disease prevention in people living with HIV: from REPRIEVE to a statin of grace.
- Published in:
- European Heart Journal, 2023, v. 44, n. 41, p. 4308, doi. 10.1093/eurheartj/ehad594
- By:
- Publication type:
- Article
Acute myocardial infarction is associated with faster age-related cognitive decline.
- Published in:
- European Heart Journal, 2023, v. 44, n. 38, p. 3718, doi. 10.1093/eurheartj/ehad475
- By:
- Publication type:
- Article
Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own.
- Published in:
- European Heart Journal, 2023, v. 44, n. 35, p. 3309, doi. 10.1093/eurheartj/ehad467
- By:
- Publication type:
- Article
Heart failure and socioeconomic status: global differences and inequalities.
- Published in:
- European Heart Journal, 2023, v. 44, n. 32, p. 3038, doi. 10.1093/eurheartj/ehad410
- By:
- Publication type:
- Article
Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 26, p. 2363, doi. 10.1093/eurheartj/ehad348
- By:
- Publication type:
- Article
Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation?
- Published in:
- European Heart Journal, 2023, v. 44, n. 22, p. 1973, doi. 10.1093/eurheartj/ehad241
- By:
- Publication type:
- Article
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients?
- Published in:
- European Heart Journal, 2023, v. 44, n. 21, p. 1860, doi. 10.1093/eurheartj/ehad206
- By:
- Publication type:
- Article
'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes.
- Published in:
- European Heart Journal, 2023, v. 44, n. 18, p. 1592, doi. 10.1093/eurheartj/ehad166
- By:
- Publication type:
- Article
Aspirin for venous thromboprophylaxis after fracture: ready for prime time?
- Published in:
- European Heart Journal, 2023, v. 44, n. 15, p. 1299, doi. 10.1093/eurheartj/ehad098
- By:
- Publication type:
- Article
Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease.
- Published in:
- European Heart Journal, 2023, v. 44, n. 12, p. 1016, doi. 10.1093/eurheartj/ehad014
- By:
- Publication type:
- Article
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions.
- Published in:
- European Heart Journal, 2023, v. 44, n. 9, p. 711, doi. 10.1093/eurheartj/ehac808
- By:
- Publication type:
- Article
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 641, doi. 10.1093/eurheartj/ehac754
- By:
- Publication type:
- Article
A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 7, p. 549, doi. 10.1093/eurheartj/ehac732
- By:
- Publication type:
- Article
Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
- Published in:
- European Heart Journal, 2023, v. 44, n. 6, p. 443, doi. 10.1093/eurheartj/ehac721
- By:
- Publication type:
- Article
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 4, p. 262, doi. 10.1093/eurheartj/ehac515
- By:
- Publication type:
- Article
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges.
- Published in:
- European Heart Journal, 2023, v. 44, n. 3, p. 178, doi. 10.1093/eurheartj/ehac649
- By:
- Publication type:
- Article
Fifty years with aspirin and platelets.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 1, p. 25, doi. 10.1111/bph.15966
- By:
- Publication type:
- Article
Solid evidence that very few muscle symptoms are due to statin therapy.
- Published in:
- European Heart Journal, 2023, v. 44, n. 1, p. 12, doi. 10.1093/eurheartj/ehac620
- By:
- Publication type:
- Article
Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 12, p. 2958, doi. 10.1111/cts.13415
- By:
- Publication type:
- Article
Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4456, doi. 10.1093/eurheartj/ehac503
- By:
- Publication type:
- Article
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practice.
- Published in:
- European Heart Journal, 2022, v. 43, n. 40, p. 3995, doi. 10.1093/eurheartj/ehac469
- By:
- Publication type:
- Article
One-shot thrombolysis for the management of acute ischaemic stroke.
- Published in:
- European Heart Journal, 2022, v. 43, n. 38, p. 3616, doi. 10.1093/eurheartj/ehac457
- By:
- Publication type:
- Article
Dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonism for substantial body weight reduction in obese subjects.
- Published in:
- European Heart Journal, 2022, v. 43, n. 35, p. 3288, doi. 10.1093/eurheartj/ehac384
- By:
- Publication type:
- Article
Aspirin: 1A @ 125.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3194, doi. 10.1093/eurheartj/ehac416
- By:
- Publication type:
- Article
absolute cardiovascular benefits of PCSK9 inhibitors and ezetimibe added to maximally tolerated statin therapy depend on individual baseline cardiovascular risk.
- Published in:
- European Heart Journal, 2022, v. 43, n. 32, p. 3016, doi. 10.1093/eurheartj/ehac360
- By:
- Publication type:
- Article
Efficacy of a Mediterranean diet for the secondary prevention of cardiovascular disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 29, p. 2727, doi. 10.1093/eurheartj/ehac314
- By:
- Publication type:
- Article
Placing the risk of myopericarditis following COVID-19 vaccination into perspective.
- Published in:
- European Heart Journal, 2022, v. 43, n. 27, p. 2547, doi. 10.1093/eurheartj/ehac296
- By:
- Publication type:
- Article
novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 25, p. 2354, doi. 10.1093/eurheartj/ehac250
- By:
- Publication type:
- Article
PACMAN-AMI trial: game over for the "vulnerable plaque"?
- Published in:
- European Heart Journal, 2022, v. 43, n. 23, p. 2179, doi. 10.1093/eurheartj/ehac222
- By:
- Publication type:
- Article
Increased risk of incident diabetes in patients with long COVID.
- Published in:
- European Heart Journal, 2022, v. 43, n. 22, p. 2094, doi. 10.1093/eurheartj/ehac196
- By:
- Publication type:
- Article
Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 17, p. 1615, doi. 10.1093/eurheartj/ehac096
- By:
- Publication type:
- Article
In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 16, p. 1531, doi. 10.1093/eurheartj/ehac090
- By:
- Publication type:
- Article
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugs.
- Published in:
- European Heart Journal, 2022, v. 43, n. 14, p. 1377, doi. 10.1093/eurheartj/ehac062
- By:
- Publication type:
- Article
Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes.
- Published in:
- European Heart Journal, 2022, v. 43, n. 12, p. 1189, doi. 10.1093/eurheartj/ehab878
- By:
- Publication type:
- Article
Can targeting factor XIa dissociate thrombosis from haemostasis?
- Published in:
- European Heart Journal, 2022, v. 43, n. 11, p. 1031, doi. 10.1093/eurheartj/ehab871
- By:
- Publication type:
- Article
Give genotype-guided dual antiplatelet therapy a second CHANCE.
- Published in:
- European Heart Journal, 2022, v. 43, n. 10, p. 938, doi. 10.1093/eurheartj/ehac024
- By:
- Publication type:
- Article
Can low-dose aspirin help the RECOVERY of patients hospitalized with COVID-19?
- Published in:
- European Heart Journal, 2022, v. 43, n. 8, p. 714, doi. 10.1093/eurheartj/ehab907
- By:
- Publication type:
- Article